A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
Evaluation of Virologic, Immunologic, and Clinical Parameters of Participants in HIVNET 014 Who Become Infected With HIV-1
1 other identifier
observational
N/A
1 country
11
Brief Summary
The purpose of this study is to evaluate the long-term consequences of HIV-1 infections that occurred in association with known, but discouraged, high-risk behaviors in persons who have received HIV candidate vaccines or placebo in HIVNET 014. Doctors need to look at how these patients respond to HIV infection in order to develop new HIV vaccines and other treatments for HIV and AIDS. Patients who receive HIV vaccines are sometimes protected from HIV infection. More often, these patients become HIV-positive but experience a boost in their immune system that helps their bodies fight HIV. Doctors need to look at how these patients respond to HIV infection in order to develop new HIV vaccines and other treatments for HIV and AIDS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 1999
CompletedFirst Submitted
Initial submission to the registry
November 2, 1999
CompletedFirst Posted
Study publicly available on registry
August 31, 2001
CompletedSeptember 12, 2008
June 1, 2003
November 2, 1999
September 11, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Patients may be eligible for this study if they:
- Become infected with HIV while participating in HIVNET 014, or if they are an HIV-positive partner (sexual or needle-sharing) of a HIVNET 014A participant.
- Are able and willing to provide written informed consent.
You may not qualify if:
- Patients will not be eligible for this study if they:
- Have a serious psychiatric or psychological disorder that would prevent them from completing the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
San Francisco Dept of Hlth / AIDS Office
San Francisco, California, 94102, United States
Denver Dept of Public Health / HIVNET
Denver, Colorado, 80204, United States
Univ of Illinois Chicago / Howard Brown Hlth Ctr
Chicago, Illinois, 60612, United States
Howard Brown Health Ctr / HIVNET
Chicago, Illinois, 60657, United States
Fenway Community Health Ctr / HIVNET
Boston, Massachusetts, 02115, United States
New York Univ Med Ctr
New York, New York, 10016, United States
New York Blood Ctr
The Bronx, New York, 10456, United States
Univ of Pennsylvania / HIVNET
Philadelphia, Pennsylvania, 19104, United States
Mem Hosp of Rhode Island
Pawtucket, Rhode Island, 02860, United States
Miriam Hosp
Providence, Rhode Island, 02906, United States
Univ of Washington
Seattle, Washington, 98104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Connie Celum
- STUDY CHAIR
Susan Buchbinder
- STUDY CHAIR
Haynes Sheppard
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
November 2, 1999
First Posted
August 31, 2001
Study Start
August 1, 1999
Last Updated
September 12, 2008
Record last verified: 2003-06